Introducing <i>iNew Medicine</i> : Advancing the New Frontiers of Healthcare Innovation

We are pleased to announce the launch of iNew Medicine, a peer-reviewed, open-access interdisciplinary journal with a focus on the latest advances in medical science and healthcare. Today, as medicine merges with cutting-edge engineering and technology, we are entering a new era of innovation. This shift is leading to powerful new platforms such as artificial intelligence, gene editing, regenerative therapies, brain-computer interfaces, and next-generation biomaterials. iNew Medicine emerges from this transformative convergence, offering a platform to explore and share these groundbreaking developments that are shaping the future of medicine. In an era of accelerating change, the need to break down disciplinary boundaries and harness scientific disruption is more pressing than ever. Medicine is no longer confined to the clinic or the lab, it is now situated at the nexus of innovation, data, ethics, and society. iNew Medicine stands at this crossroads, dedicated to exploring transformative medical technologies and therapies, and the profound implications they hold for the future of health, society, and humanity at large. The name iNew Medicine reflects our commitment to “innovative” and “interdisciplinary” perspectives in medicine. We embrace the most impactful medical breakthroughs, not purely biological, but bio-digital, bio-engineered, and algorithmically guided. Our mission is to serve as a scholarly hub for high-quality research that informs, challenges, and inspires future generations. iNew Medicine is committed to publishing cutting-edge developments while fostering critical reflection on the implications of these advances scientifically, clinically, ethically, and globally. Advanced Medical Materials and Biomaterials Artificial Intelligence (AI) and Machine Learning Basic Science Research with Translational Insights and Relevance Big Data and Large Language Models Biomedical Engineering Brain-Computer Interfaces and Neural Engineering Clinical Trials and Experimental Therapeutics Drug Discovery and Development Disease Prevention and Public Health Technologies Gene Editing and Synthetic Biology Translational Pharmacological Sciences Regenerative Medicine and Tissue Engineering Translational and Precision Medicine This multi-dimensional scope enables the journal to remain at the forefront of discovery, while ensuring the integration of research efforts across sectors and specialties. From bench to bedside, and from code to clinic, iNew Medicine seeks to be the nexus of the future. In keeping with our commitment to fostering comprehensive scientific dialog, iNew Medicine will publish a diverse array of article types, including, Original Research Articles, Brief Communications, Invited Reviews, Editorials and Perspectives addressing paradigm shifts, ethical dilemmas, or future directions in innovative medicine. Whether reporting first-in-human trials, conceptual advances in understanding disease mechanisms, or the development of AI-powered diagnostic models, our priority is quality, originality, and relevance. The journal prioritizes translational medicine, the transformation of scientific discoveries into practical clinical applications, and highlights conceptual breakthroughs that redefine our understanding of diseases and treatments. We also actively encourage exploratory research that proposes novel hypotheses or challenges fundamental assumptions in medicine. In iNew Medicine, we are deeply engaged with the societal and ethical questions that come with today's medical technologies. As innovation moves faster than ever, challenges around access, fairness, and real-world impact become increasingly urgent. Should AI be entrusted with life-and-death medical decisions? How should we regulate gene editing in embryos? Who owns patient-generated health data in a big-data ecosystem? How can we ensure global equity in accessing high-cost, high-tech therapies? These are not peripheral questions, they are central to the future of medicine. As such, we welcome submissions that explore the implications of emerging technologies through ethical, legal, policy, and sociocultural lenses. Science today must be open, inclusive, and globally accessible. iNew Medicine adheres to principles of open-access publishing to ensure that knowledge is not locked behind paywalls, but is freely available to clinicians in rural hospitals, researchers in low-resource settings, students in developing countries, and innovators worldwide. We also prioritize global representation in our editorial board, authorship, peer reviewers, and coverage. Innovation is not geographically bound, and we are committed to amplifying voices and discoveries from all corners of the world. We invite you, clinicians, scientists, engineers, ethicists, entrepreneurs to join us on the journey of iNew Medicine. Whether you are submitting your latest breakthrough, reviewing the work of your peers, or simply staying informed about the evolution of health science, your participation helps shape a healthier, smarter, and more equitable world. With iNew Medicine, we are not just publishing science, and we are helping to define the future of medicine. Y. Eugene Chen: conceptualization, writing – original draft, writing – review and editing. Jianping Weng: conceptualization, writing – review and editing. The authors declare no conflicts of interest.